肺癌患者-话题@MedSci

#肺癌患者#

303篇内容 | 5550人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1990600, encodeId=3c301990600d0, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=SCI REP：外周血和肺静脉血循环肿瘤细胞预测非小细胞肺癌患者的长期生存率！, objectType=article, longId=105239, objectId=8abb10523993, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8abb10523993, replyNumber=0, likeNumber=69, createdTime=2017-12-16, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8abb10523993, moduleTitle=SCI REP：外周血和肺静脉血循环肿瘤细胞预测非小细胞肺癌患者的长期生存率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8abb10523993)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990569, encodeId=d260199056966, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=BJC：步行能改善肺癌患者的睡眠, objectType=article, longId=82267, objectId=016e8226e77, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=016e8226e77, replyNumber=0, likeNumber=75, createdTime=2017-07-24, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=016e8226e77, moduleTitle=BJC：步行能改善肺癌患者的睡眠, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=016e8226e77)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990595, encodeId=ddf51990595c3, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=NAT IMMUNOL:惊喜！科学家发现特殊免疫细胞让肺癌患者10年死亡率更高降低60%, objectType=article, longId=103910, objectId=403c103910eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=403c103910eb, replyNumber=0, likeNumber=79, createdTime=2018-03-30, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=403c103910eb, moduleTitle=NAT IMMUNOL:惊喜！科学家发现特殊免疫细胞让肺癌患者10年死亡率更高降低60%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=403c103910eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990582, encodeId=fef11990582b5, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Plos One：非小细胞肺癌患者的EGFR突变比例与TKI治疗密切相关！, objectType=article, longId=99253, objectId=4acb9925322, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4acb9925322, replyNumber=0, likeNumber=57, createdTime=2017-10-26, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4acb9925322, moduleTitle=Plos One：非小细胞肺癌患者的EGFR突变比例与TKI治疗密切相关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4acb9925322)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990591, encodeId=08db19905917b, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=JAMA Oncol：PET / CT用于局部晚期非小细胞肺癌患者, objectType=article, longId=102443, objectId=b69810244381, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b69810244381, replyNumber=0, likeNumber=62, createdTime=2017-08-10, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b69810244381, moduleTitle=JAMA Oncol：PET / CT用于局部晚期非小细胞肺癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b69810244381)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990583, encodeId=5b871990583d0, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=PLoS One：非小细胞肺癌患者的EGFR突变比例与TKI治疗密切相关！, objectType=article, longId=99620, objectId=b9739962011, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9739962011, replyNumber=0, likeNumber=38, createdTime=2017-11-26, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9739962011, moduleTitle=PLoS One：非小细胞肺癌患者的EGFR突变比例与TKI治疗密切相关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9739962011)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990575, encodeId=214319905e579, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=新一代靶向药物在中国获批肺癌患者迎来新希望, objectType=article, longId=90249, objectId=ce54902494b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce54902494b, replyNumber=0, likeNumber=69, createdTime=2017-03-26, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce54902494b, moduleTitle=新一代靶向药物在中国获批肺癌患者迎来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce54902494b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990589, encodeId=29211990589b7, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Lancet Oncol：色瑞替尼用于克唑替尼耐药的ALK阳性非小细胞肺癌患者, objectType=article, longId=101275, objectId=d71d1012e5ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d71d1012e5ac, replyNumber=0, likeNumber=72, createdTime=2017-12-07, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d71d1012e5ac, moduleTitle=Lancet Oncol：色瑞替尼用于克唑替尼耐药的ALK阳性非小细胞肺癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d71d1012e5ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990564, encodeId=21ae199056436, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Lancet Oncol：乳腺癌和肺癌患者全身抗癌治疗后30天死亡率研究, objectType=article, longId=76929, objectId=7de1e6929db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7de1e6929db, replyNumber=0, likeNumber=138, createdTime=2017-04-10, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7de1e6929db, moduleTitle=Lancet Oncol：乳腺癌和肺癌患者全身抗癌治疗后30天死亡率研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7de1e6929db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990559, encodeId=4390199055946, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=肺癌患者福音！苏格兰医药协会批准两款NSCLC新药, objectType=article, longId=73097, objectId=43abe309703, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43abe309703, replyNumber=0, likeNumber=0, createdTime=2017-04-30, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43abe309703, moduleTitle=肺癌患者福音！苏格兰医药协会批准两款NSCLC新药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43abe309703)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990581, encodeId=0aeb1990581b3, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Chest：非小细胞肺癌患者采用PD-1和PD-L1抑制剂肺炎发生率有何差异？, objectType=article, longId=98586, objectId=24189858651, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24189858651, replyNumber=0, likeNumber=79, createdTime=2017-08-01, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24189858651, moduleTitle=Chest：非小细胞肺癌患者采用PD-1和PD-L1抑制剂肺炎发生率有何差异？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24189858651)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990580, encodeId=b4651990580ce, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Eur J Cancer:高水平超敏C反应蛋白在肺癌患者中的影响的研究进展, objectType=article, longId=98075, objectId=ca64980e5fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca64980e5fb, replyNumber=0, likeNumber=77, createdTime=2017-12-24, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca64980e5fb, moduleTitle=Eur J Cancer:高水平超敏C反应蛋白在肺癌患者中的影响的研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca64980e5fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990579, encodeId=41d819905e96c, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=J Mol Diagn：血液检测可使肺癌患者获得早期的个性化治疗, objectType=article, longId=96525, objectId=e04c96525ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e04c96525ee, replyNumber=0, likeNumber=80, createdTime=2017-11-12, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e04c96525ee, moduleTitle=J Mol Diagn：血液检测可使肺癌患者获得早期的个性化治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e04c96525ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990572, encodeId=bbad19905e21b, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Lancet：非小细胞肺癌患者是用多西他赛还是Atezolizumab？, objectType=article, longId=84183, objectId=451a8418304, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=451a8418304, replyNumber=0, likeNumber=65, createdTime=2017-04-10, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=451a8418304, moduleTitle=Lancet：非小细胞肺癌患者是用多西他赛还是Atezolizumab？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=451a8418304)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990567, encodeId=004f199056e96, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=ESMO 2016：Ceritinib可延长ALK阳性非小细胞肺癌患者的PFS, objectType=article, longId=79864, objectId=5769e986481, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5769e986481, replyNumber=0, likeNumber=74, createdTime=2017-09-26, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5769e986481, moduleTitle=ESMO 2016：Ceritinib可延长ALK阳性非小细胞肺癌患者的PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5769e986481)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990561, encodeId=e1f219905610f, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=PLoS Comput Biol：抑制肺癌患者对药物产生耐受性的新策略, objectType=article, longId=76081, objectId=b1b0e60815a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1b0e60815a, replyNumber=0, likeNumber=68, createdTime=2017-06-17, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1b0e60815a, moduleTitle=PLoS Comput Biol：抑制肺癌患者对药物产生耐受性的新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1b0e60815a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990565, encodeId=f0a31990565cc, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=ASTRO 2016：立体定向放射治疗增加早期非小细胞肺癌患者的生存率, objectType=article, longId=78842, objectId=538ae8842d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=538ae8842d1, replyNumber=0, likeNumber=71, createdTime=2016-12-01, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=538ae8842d1, moduleTitle=ASTRO 2016：立体定向放射治疗增加早期非小细胞肺癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=538ae8842d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990568, encodeId=fa711990568d3, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=J Thromb Haemost：Khorana评分不能预测肺癌患者的静脉栓塞风险, objectType=article, longId=80813, objectId=1b5a8081369, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b5a8081369, replyNumber=0, likeNumber=73, createdTime=2017-05-09, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b5a8081369, moduleTitle=J Thromb Haemost：Khorana评分不能预测肺癌患者的静脉栓塞风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b5a8081369)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990563, encodeId=3a2c199056330, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=老年晚期肺癌患者：如何进行药物选择, objectType=article, longId=76597, objectId=2e39e65970b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e39e65970b, replyNumber=0, likeNumber=66, createdTime=2017-02-23, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e39e65970b, moduleTitle=老年晚期肺癌患者：如何进行药物选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e39e65970b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990560, encodeId=500d19905601c, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=全球首例！脂肪干细胞治愈肺癌患者术后渗漏并发症, objectType=article, longId=73353, objectId=c967e3353ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c967e3353ca, replyNumber=0, likeNumber=107, createdTime=2016-10-24, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c967e3353ca, moduleTitle=全球首例！脂肪干细胞治愈肺癌患者术后渗漏并发症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c967e3353ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肺癌患者

2020-05-29

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

SCI REP：外周血和肺静脉血循环肿瘤细胞预测非小细胞肺癌患者的长期生存率！

2017-12-16

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

BJC：步行能改善肺癌患者的睡眠

2017-07-24

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

NAT IMMUNOL:惊喜！科学家发现特殊免疫细胞让肺癌患者10年死亡率更高降低60%

2018-03-30

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Plos One：非小细胞肺癌患者的EGFR突变比例与TKI治疗密切相关！

2017-10-26

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

JAMA Oncol：PET / CT用于局部晚期非小细胞肺癌患者

2017-08-10

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

PLoS One：非小细胞肺癌患者的EGFR突变比例与TKI治疗密切相关！

2017-11-26

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

新一代靶向药物在中国获批肺癌患者迎来新希望

2017-03-26

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Lancet Oncol：色瑞替尼用于克唑替尼耐药的ALK阳性非小细胞肺癌患者

2017-12-07

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Lancet Oncol：乳腺癌和肺癌患者全身抗癌治疗后30天死亡率研究

2017-04-10

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

肺癌患者福音！苏格兰医药协会批准两款NSCLC新药

2017-04-30

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Chest：非小细胞肺癌患者采用PD-1和PD-L1抑制剂肺炎发生率有何差异？

2017-08-01

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Eur J Cancer:高水平超敏C反应蛋白在肺癌患者中的影响的研究进展

2017-12-24

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

J Mol Diagn：血液检测可使肺癌患者获得早期的个性化治疗

2017-11-12

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Lancet：非小细胞肺癌患者是用多西他赛还是Atezolizumab？

2017-04-10

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

ESMO 2016：Ceritinib可延长ALK阳性非小细胞肺癌患者的PFS

2017-09-26

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

PLoS Comput Biol：抑制肺癌患者对药物产生耐受性的新策略

2017-06-17

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

ASTRO 2016：立体定向放射治疗增加早期非小细胞肺癌患者的生存率

2016-12-01

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

J Thromb Haemost：Khorana评分不能预测肺癌患者的静脉栓塞风险

2017-05-09

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

老年晚期肺癌患者：如何进行药物选择

2017-02-23

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

全球首例！脂肪干细胞治愈肺癌患者术后渗漏并发症

2016-10-24

科室
- - 订阅+
  - 更多科室
工具
服务